The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
Open accessAbstract
Cancer cells engage in a metabolic program to enhance biosynthesis and support cell proliferation. The regulatory properties of pyruvate kinase M2 (PKM2) influence altered glucose metabolism in cancer. The interaction of PKM2 with phosphotyrosine-containing proteins inhibits enzyme activity and increases the availability of glycolytic metabolites to support cell proliferation. This suggests that high pyruvate kinase activity may suppress tumor growth. We show that expression of PKM1, the pyruvate kinase isoform with high constitutive activity, or exposure to published small-molecule PKM2 activators inhibits the growth of xenograft tumors. Structural studies reveal that small-molecule activators bind PKM2 at the subunit interaction interface, a site that is distinct from that of the endogenous activator fructose-1,6-bisphosphate (FBP). However, unlike FBP, binding of activators to PKM2 promotes a constitutively active enzyme state that is resistant to inhibition by tyrosine-phosphorylated proteins. These data support the notion that small-molecule activation of PKM2 can interfere with anabolic metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, activation of pyruvate kinase can inhibit cancer cell proliferation and tumor growth in some settings (Anastasiou et al., 2012; Kung et al., 2012; Walsh et al., 2010), but because pyruvate kinase expression is dispensable for the growth of some tumors (Cortes-Cros et al., 2013; Israelsen et al., 2013), whether pyruvate kinase activation will lead to durable responses remains an area of”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Anastasiou et al., 2012
In the citing paper
“Activating PKM2 by using small-molecule agonists increases PEP-to-pyruvate conversion, reducing the flux of glycolytic intermediates toward anabolic pathways and slowing tumor cell growth (56, 60).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [56]
In the citing paper
“PKM2 exists as either an inactive dimer or an active tetramer, and oscillation between these two states influences the ability of cells to maintain anabolic metabolism (56).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [56]
In the citing paper
“In order to examine the functional relevance of PKM2 for LPS action we next examined the effect of two highly specific small-molecule PKM2 activators, TEPP-46 and DASA-58.”
From Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages (2015) · cites this paper as Anastasiou et al., 2012
In the citing paper
“TEPP-46, but not DASA-58, is pharmacokinetically validated in vivo (Anastasiou et al., 2012).”
From Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages (2015) · cites this paper as Anastasiou et al., 2012
In the citing paper
“These well-characterized and highly specific compounds bind PKM2, which then forms a tight tetramer with PKM1-like kinetic properties, an event that is resistant to inhibition by tyrosine phosphorylation.”
From Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages (2015) · cites this paper as Anastasiou et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Colowick, S. P., Joshi, M. D., Jagannathan, & KAPLAN, N. O. (1966) · Cited by 26,137
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citationRefinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,796
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
PRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,837
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ho, P.-C., Bihuniak, J. D., Macintyre, A. N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.-C., Cui, G., Micevic, G., Perales, J. C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.012 · Cited by 1,462
Palsson-McDermott, E. M., Curtis, A. M., Goel, G., Lauterbach, M. A. R., Sheedy, F. J., Gleeson, L. E., van den Bosch, M. W. M., Quinn, S. R., Domingo-Fernandez, R., Johnston, D. G. W., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.005 · Cited by 1,397
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript active PKM2 tetramers thereby boosting PKM2 enzymatic activity and limiting tumor growth in vivo (Anastasiou et al., 2012).”
InfluentialSelf-citationFueling Immunity: Insights into Metabolism and Lymphocyte Function
Pearce, E. L., Poffenberger, M. C., Chang, C.-H., & Jones, R. G. (2013) · Science · doi:10.1126/science.1242454 · Cited by 1,363
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Schulze, A., & Harris, A. L. (2012) · Nature · doi:10.1038/nature11706 · Cited by 945
Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression
Li, Z., & Zhang, H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2070-4 · Cited by 840
Metabolic targets for cancer therapy
Galluzzi, L., Kepp, O., Heiden, M. G. V., & Kroemer, G. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4145 · Cited by 731
Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma
Feng, J., Li, J., Wu, L., Yu, Q., Ji, J., Wu, J., Dai, W., & Guo, C. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01629-4 · Cited by 706
Zheng, X., Boyer, L., Jin, M., Mertens, J., Kim, Y., Ma, L., Ma, L., Hamm, M., Gage, F. H., & Hunter, T. (2016) · eLife · doi:10.7554/elife.13374 · Cited by 671
“PKM1 is constitutively active, while, PKM2 is subjected to allosteric regulation and can adopt a low or high activity state (Anastasiou et al., 2012).”
BackgroundMetabolomics in cancer research and emerging applications in clinical oncology
Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Heiden, M. G. V., & Locasale, J. W. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 675
Pyruvate kinase: Function, regulation and role in cancer
Israelsen, W. J., & Heiden, M. G. V. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.08.004 · Cited by 608
Self-citationA PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate
Pacold, M. E., Brimacombe, K. R., Chan, S. H., Rohde, J. M., Lewis, C. A., Swier, L. J. Y. M., Possemato, R., Chen, W. W., Sullivan, L. B., Fiske, B. P., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2070 · Cited by 553
Self-citationPKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells
Israelsen, W. J., Dayton, T. L., Davidson, S. M., Fiske, B. P., Hosios, A. M., Bellinger, G., Li, J., Yu, Y., Sasaki, M., Horner, J. W., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.025 · Cited by 549
Self-citationThe Warburg effect then and now: From cancer to inflammatory diseases
Pålsson‐McDermott, E. M., & O'Neill, L. A. J. (2013) · BioEssays · doi:10.1002/bies.201300084 · Cited by 553
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalaf, K., Hana, D., Chou, J. T.-T., Singh, C., Mackiewicz, A. A., & Kaczmarek, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656364 · Cited by 551
PKM2, cancer metabolism, and the road ahead
Dayton, T. L., Jacks, T., & Vander Heiden, M. G. (2016) · The EMBO Reports · doi:10.15252/embr.201643300 · Cited by 515
Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis
Zahra, K., Dey, T., Ashish, Mishra, S. P., & Pandey, U. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00159 · Cited by 526
PKM2, function and expression and regulation
Zhang, Z., Deng, X., Liu, Y., Liu, Y., Sun, L., & Chen, F. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0317-8 · Cited by 518
Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis
Fearon, U., Canavan, M., Biniecka, M., & Veale, D. J. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.69 · Cited by 455
Martinez-Outschoorn, U. E., Lisanti, M. P., & Sotgia, F. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.005 · Cited by 423
The importance of serine metabolism in cancer
Mattaini, K. R., Sullivan, M. R., & Heiden, M. G. V. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201604085 · Cited by 423
Self-citationHeterogeneity of tumor-induced gene expression changes in the human metabolic network
Hu, J., Locasale, J. W., Bielas, J. H., O'Sullivan, J., Sheahan, K., Cantley, L. C., Heiden, M. G. V., & Vitkup, D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2530 · Cited by 407
Self-citationAltered metabolite levels in cancer: implications for tumour biology and cancer therapy
Sullivan, L. B., Gui, D. Y., & Heiden, M. G. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.85 · Cited by 406
Daemen, A., Peterson, D., Sahu, N., McCord, R., Du, X., Liu, B., Kowanetz, K., Hong, R., Moffat, J., Gao, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501605112 · Cited by 398
Urbanski, L. M., Leclair, N. K., & Anczuków, O. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1476 · Cited by 393
The ERK and JNK pathways in the regulation of metabolic reprogramming
Papa, S., Choy, P. M., & Bubici, C. (2018) · Oncogene · doi:10.1038/s41388-018-0582-8 · Cited by 394
SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance
Kim, D., Fiske, B. P., Birsoy, K., Freinkman, E., Kami, K., Possemato, R. L., Chudnovsky, Y., Pacold, M. E., Chen, W. W., Cantor, J. R., et al. (2015) · Nature · doi:10.1038/nature14363 · Cited by 368
Self-citationUnderstanding metabolic regulation and its influence on cell physiology
Metallo, C. M., & Vander Heiden, M. G. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.018 · Cited by 367
Self-citationCell-State-Specific Metabolic Dependency in Hematopoiesis and Leukemogenesis
Wang, Y., Israelsen, W. J., Lee, D., Yu, V. W. C., Jeanson, N. T., Clish, C. B., Cantley, L. C., Heiden, M. G. V., & Scadden, D. T. (2014) · Cell · doi:10.1016/j.cell.2014.07.048 · Cited by 367
Self-citationPKM2 contributes to cancer metabolism
Wong, N., Ojo, D., Yan, J., & Tang, D. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.031 · Cited by 349
Wang, F., Wang, K., Xu, W., Zhao, S., Ye, D., Wang, Y., Xu, Y., Zhou, L., Chu, Y., Zhang, C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.065 · Cited by 340
Cancer‐generated lactic acid: a regulatory, immunosuppressive metabolite?
Choi, S. Y. C., Collins, C. C., Gout, P. W., & Wang, Y. Z. (2013) · The Journal of Pathology · doi:10.1002/path.4218 · Cited by 339
Advances in covalent kinase inhibitors
Abdeldayem, A., Raouf, Y. S., Constantinescu, S. N., Moriggl, R., & Gunning, P. T. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00720b · Cited by 337
PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation
Azoitei, N., Becher, A., Steinestel, K., ROUHI, A. M., Diepold, K., Genze, F., Simmet, T., & Seufferlein, T. T. W. (2016) · Molecular Cancer · doi:10.1186/s12943-015-0490-2 · Cited by 346
Lv, L., Xu, Y.-P., Zhao, D., Li, F.-L., Wang, W., Sasaki, N., Jiang, Y., Zhou, X., Li, T.-T., Guan, K., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.004 · Cited by 339
Mullarky, E., Lucki, N. C., Beheshti Zavareh, R., Anglin, J. L., Gomes, A. P., Nicolay, B. N., Wong, J. C. Y., Christen, S., Takahashi, H., Singh, P. K., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521548113 · Cited by 333
Self-citationPKM2 and cancer: The function of PKM2 beyond glycolysis
Dong, G., Mao, Q., XIA, W., Xu, Y., Wang, J., Xu, L., & JIANG, F. (2016) · Oncology Letters · doi:10.3892/ol.2016.4168 · Cited by 337
Angiari, S., Runtsch, M. C., Sutton, C. E., Pålsson‐McDermott, E. M., Kelly, B. L., Rana, N., Kane, H., Papadopoulou, G., Pearce, E. L., Mills, K. H. G., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.10.015 · Cited by 314
Dysregulated metabolism contributes to oncogenesis
Hirschey, M. D., DeBerardinis, R. J., Diehl, A. M., Drew, J. E., Frezza, C., Green, M. F., Jones, L. W., Ko, Y. H., Le, A., Lea, M. A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.10.002 · Cited by 316
PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis
Liu, F., Ma, F., Wang, Y., Hao, L., Zeng, H., Jia, C., Wang, Y., Liu, P., Ong, I. M., Li, B., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3630 · Cited by 306
Self-citationAgnihotri, S., & Zadeh, G. M. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov125 · Cited by 302
ROS homeostasis and metabolism: a critical liaison for cancer therapy
Kim, J., Kim, J., & Bae, J. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.119 · Cited by 304
Dietary fructose improves intestinal cell survival and nutrient absorption
Taylor, S. R., Ramsamooj, S., Liang, R. J., Katti, A., Pozovskiy, R., Vasan, N., Hwang, S.-K., Nahiyaan, N., Francoeur, N. J., Schatoff, E. M., et al. (2021) · Nature · doi:10.1038/s41586-021-03827-2 · Cited by 288
Self-citationPKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation
Damasceno, L. E. A., Prado, D. D. S., Veras, F. P., Fonseca, M. M., Toller-Kawahisa, J. E., Rosa, M. H., Públio, G. A., Martins, T. V., Ramalho, F. S., Waisman, A., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190613 · Cited by 293
Metabolic Enzymes Moonlighting in the Nucleus: Metabolic Regulation of Gene Transcription
Boukouris, A. E., Zervopoulos, S. D., & Michelakis, E. D. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.05.013 · Cited by 289
The Influence of Metabolism on Drug Response in Cancer
Zaal, E. A., & Berkers, C. R. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00500 · Cited by 272
Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics
Zhu, S., Guo, Y., Zhang, X., Liu, H., Yin, M., Chen, X., & Peng, C. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.018 · Cited by 278
Lim, S., Li, C., Xia, W., Lee, H., Chang, S.-S., Shen, J., Hsu, J. L., Raftery, D., Djukovic, D., Gu, H., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2478 · Cited by 270
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology
Sutendra, G., & Michelakis, E. D. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00038 · Cited by 275
Pyruvate Kinase Isoform Expression Alters Nucleotide Synthesis to Impact Cell Proliferation
Lunt, S. Y., Muralidhar, V., Hosios, A. M., Israelsen, W. J., Gui, D. Y., Newhouse, L., Ogrodzinski, M. P., Hecht, V. C., Xu, K., Acevedo, P. N. M., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.027 · Cited by 263
Self-citationZhang, H., Wang, D., Li, M., Plecitá‐Hlavatá, L., D’Alessandro, A., Tauber, J. A., Riddle, S. R., Kumar, S., Flockton, A. R., McKeon, B. A., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.028069 · Cited by 250
PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation
Li, T., Han, J., Jia, L., Hu, X., Chen, L., & Wang, Y. (2019) · Protein & Cell · doi:10.1007/s13238-019-0618-z · Cited by 251
Alfarouk, K. O., Verduzco, D., Rauch, C., Muddathir, A. K., Bashir, A. H. H., Elhassan, G. O., Ibrahim, M. E., Orozco, J. D. P., Cardone, R. A., Reshkin, S. J., et al. (2014) · Oncoscience · doi:10.18632/oncoscience.109 · Cited by 255
PKM2, a Central Point of Regulation in Cancer Metabolism
Wong, N., Melo, J. D., & Tang, D. (2013) · International Journal of Cell Biology · doi:10.1155/2013/242513 · Cited by 245
Billiard, J., Dennison, J. B., Briand, J., Annan, R. S., Chai, D., Colón, M., Dodson, C. S., Gilbert, S. A., Greshock, J. D., Jing, J., et al. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-19 · Cited by 237
Rao, J., Wang, H., Ni, M., Wang, Z., Wang, Z., Wei, S., Liu, M., Wang, P., Qiu, J., Zhang, L., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325150 · Cited by 241
Iansante, V., Choy, P. M., Fung, S. W., Liu, Y., Chai, J.-G., Dyson, J., Río, A. D., D’Santos, C. S., Williams, R. L., Chokshi, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8882 · Cited by 245
The Warburg effect: Evolving interpretations of an established concept
Chen, X., Qian, Y., & Wu, S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.08.027 · Cited by 234
Is Cancer a Metabolic Disease?
Coller, H. A. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.07.035 · Cited by 244
Cancer Metabolism: Current Understanding and Therapies
Counihan, J. L., Grossman, E. A., & Nomura, D. K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00775 · Cited by 236
Metabolic reprogramming by the S-nitroso-CoA reductase system protects against kidney injury
Zhou, H., Zhang, R., Anand, P., Stomberski, C. T., Qian, Z., Hausladen, A., Wang, L., Rhee, E. P., Parikh, S. M., Karumanchi, S. A., et al. (2018) · Nature · doi:10.1038/s41586-018-0749-z · Cited by 211
Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways
Onodera, Y., Nam, J., & Bissell, M. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63146 · Cited by 213
The Rheumatoid Arthritis-Associated Citrullinome
Tilvawala, R. R., Nguyen, S. H., Maurais, A. J., Nemmara, V. V., Nagar, M., Salinger, A. J., Nagpal, S., Weerapana, E., & Thompson, P. R. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.03.002 · Cited by 210
Martinez‐Outschoorn, U., Sotgia, F., & Lisanti, M. P. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.03.002 · Cited by 211
Metabolite sensing and signaling in cell metabolism
Wang, Y.-P., & Lei, Q. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0024-7 · Cited by 208
Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2
Wang, C., Li, Y., Yan, S., Wang, H., Shao, X., Xiao, M., Yang, B., Qin, G., Kong, R., Chen, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16966-3 · Cited by 206
Méndez‐Lucas, A., Hyroššová, P., Novellasdemunt, L., Viñals, F., & Perales, J. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.566927 · Cited by 205
Revisiting the role of metabolism during development
Miyazawa, H., & Aulehla, A. (2018) · Development · doi:10.1242/dev.131110 · Cited by 196
Fendt, S., Bell, E. L., Keibler, M. A., Davidson, S. M., Wirth, G. J., Fiske, B. P., Mayers, J. R., Schwab, M. G., Bellinger, G., Csibi, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0080 · Cited by 196
Self-citationPyruvate kinase M2 at a glance
Yang, W., & Lu, Z. (2015) · Journal of Cell Science · doi:10.1242/jcs.166629 · Cited by 202
Yao, W., Lu, M., Mei, M., Wang, H., Han, Z., Chen, M., Yao, H. P., Song, N., Ding, X. L., Ding, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14788-x · Cited by 198
Targeting Protein-Protein Interaction by Small Molecules
Jin, L., Wang, W., & Fang, G. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-140028 · Cited by 195
Alexander, C., Guo, Z., Glover, P. B., Faulkner, S., & Pikramenou, Z. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00615 · Cited by 203
Glycolytic reliance promotes anabolism in photoreceptors
Chinchore, Y., Begaj, T., Wu, D., Drokhlyansky, E., & Cepko, C. L. (2017) · eLife · doi:10.7554/elife.25946 · Cited by 191
Targeting Bacterial Central Metabolism for Drug Development
Murima, P., McKinney, J. D., & Pethe, K. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.020 · Cited by 194
Diverting Glycolysis to Combat Oxidative Stress
Mullarky, E., & Cantley, L. C. (2015) · Springer eBooks · doi:10.1007/978-4-431-55651-0_1 · Cited by 197
Self-citationPyruvate kinase M2 and cancer: an updated assessment
Iqbal, M. A., Gupta, V., Prakasam, G., Mazurek, S., & Bamezai, R. N. K. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.011 · Cited by 190
Reversible protein aggregation is a protective mechanism to ensure cell cycle restart after stress
Saad, S., Cereghetti, G., Feng, Y., Picotti, P., Peter, M., & Dechant, R. C. (2017) · Nature Cell Biology · doi:10.1038/ncb3600 · Cited by 186
Regulation and function of pyruvate kinase M2 in cancer
Yang, W., & Lu, Z. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.06.008 · Cited by 184
M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation
Morgan, H. P., O’Reilly, F. J., Wear, M. A., O’Neill, J. R., Fothergill‐Gilmore, L. A., Hupp, T. R., & Walkinshaw, M. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217157110 · Cited by 185
Hsu, M., & Hung, W. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0791-3 · Cited by 184
Keller, K. E., Doctor, Z. M., Dwyer, Z. W., & Lee, Y. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.02.015 · Cited by 182
Pyruvate kinase M2: A simple molecule with complex functions
Alquraishi, M. I., Puckett, D. L., Alani, D., Humidat, A. S., Frankel, V. D., Donohoe, D. R., Whelan, J. N., & Bettaieb, A. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.08.007 · Cited by 185
The multifaceted regulation and functions of PKM2 in tumor progression
Li, Z., Yang, P., & Li, Z. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.07.008 · Cited by 175
Metabolic changes in cancer: beyond the Warburg effect
Wu, W., & Zhao, S. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms104 · Cited by 173
Impact of intracellular innate immune receptors on immunometabolism
Chou, W.-C., Rampanelli, E., Li, X., & Ting, J. P. ‐. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00780-y · Cited by 173
Pyruvate Kinase M2: A Potential Target for Regulating Inflammation
Alves-Filho, J. C., & Pålsson‐McDermott, E. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00145 · Cited by 172
Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes
Schreiber, S. L., Kotz, J., Li, M., Aubé, J., Austin, C. P., Reed, J. C., Rosen, H., White, E. L., Sklar, L. A., Lindsley, C. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.023 · Cited by 173
Self-citationThe Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring
Chiaradonna, F., Ricciardiello, F., & Palorini, R. (2018) · Cells · doi:10.3390/cells7060053 · Cited by 179
Li, C., Zhang, G., Zhao, L., Ma, Z., & Chen, H. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-016-0769-9 · Cited by 175
Li, S., Swanson, S. K., Gogol, M., Florens, L. A., Washburn, M. P., Workman, J. L., & Suganuma, T. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.024 · Cited by 160
Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinomaPreprint
Dayton, T. L., Gocheva, V., Miller, K. M., Israelsen, W. J., Bhutkar, A. J., Clish, C. B., Davidson, S. M., Luengo, A., Bronson, R. T., Jacks, T., et al. (2016) · Genes & Development · doi:10.1101/gad.278549.116 · Cited by 154
Self-citationLi, G., Choi, J. E., Kryczek, I., Sun, Y., Liao, P., Li, S., Wei, S., Grove, S., Vatan, L., Nelson, R., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2022.12.008 · Cited by 161
Pyruvate and metabolic flexibility: illuminating a path toward selective cancer therapies
Olson, K. A., Schell, J. C., & Rutter, J. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.01.002 · Cited by 154
Natural Product Micheliolide (MCL) Irreversibly Activates Pyruvate Kinase M2 and Suppresses Leukemia
Li, J., Li, S., Guo, J., Li, Q., Long, J., Ma, C., Ding, Y., Yan, C., Li, L., Wu, Z., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00241 · Cited by 155
Rosa, V. D., Iommelli, F., Monti, M., Fonti, R., Votta, G., Stoppelli, M. P., & Vecchio, S. D. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0375 · Cited by 152
Li, Q., Cao, L., Tian, Y., Zhang, P., Ding, C., Lu, W., Jia, C., Shao, C., Liu, W., Wang, D., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000752 · Cited by 153
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells
Ippolito, L., Marini, A., Cavallini, L., Morandi, A., Pietrovito, L., Pintus, G., Giannoni, E., Schrader, T. H., Puhr, M., Chiarugi, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11301 · Cited by 149
Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy
Wolpaw, A. J., & Dang, C. V. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.11.006 · Cited by 151
Pyruvate Kinase Controls Signal Strength in the Insulin Secretory Pathway
Lewandowski, S. L., CARDONE, R. L., Foster, H. R., Ho, T., Potapenko, E. S., Poudel, C., VanDeusen, H. R., Sdao, S. M., Alves, T. C., Zhao, X., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.007 · Cited by 147
Self-citation
Metadata
- Authors
- Anastasiou, D., Yu, Y., Israelsen, W. J., Jiang, J.-K., Boxer, M. B., Hong, B. S., Tempel, W., Dimov, S., Shen, M., Jha, A., Yang, H., Mattaini, K. R., Metallo, C. M., Fiske, B. P., Courtney, K. D., Malstrom, S., Khan, T. M., Kung, C., Skoumbourdis, A. P., Veith, H., Southall, N., Walsh, M. J., Brimacombe, K. R., Leister, W., Lunt, S. Y., Johnson, Z. R., Yen, K. E., Kunii, K., Davidson, S. M., Christofk, H. R., Austin, C. P., Inglese, J., Harris, M. H., Asara, J. M., Stephanopoulos, G., Salituro, F. G., Jin, S., Dang, L., Auld, D. S., Park, H.-W., Cantley, L. C., Thomas, C. J., & Vander Heiden, M. G.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Massachusetts Institute of Technology (US)
- National Institutes of Health (US)
- University of Toronto (CA)
- Agios Pharmaceuticals (United States) (US)
- University of California San Diego (US)
- Boston Children's Hospital (US)
- ORCID
- Anastasiou, Dimitrios
- Yu, Yimin
- Israelsen, William J
- Jiang, Jian-Kang
- Tempel, Wolfram
- Shen, Min
- Jha, Abhishek
- Yang, Hua
- Mattaini, Katherine R
- Metallo, Christian M
- Fiske, Brian P
- Courtney, Kevin D
- Khan, Tahsin M
- Southall, Noel
- Walsh, Martin J
- Brimacombe, Kyle R
- Lunt, Sophia Y
- Johnson, Zachary R
- Yen, Katharine E
- Kunii, Kaiko
- Davidson, Shawn M
- Christofk, Heather R
- Austin, Christopher P
- Inglese, James
- Harris, Marian H
- Asara, John M
- Stephanopoulos, Gregory
- Salituro, Francesco G
- Dang, Lenny
- Auld, Douglas S
- Park, Hee-Won
- Cantley, Lewis C
- Thomas, Craig J
- Venue
- Nature Chemical Biology
- Published
- 2012-08-26
- Volume
- 8
- Issue
- 10
- Pages
- 839-847
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- PMC
- PMC3711671
- OpenAlex
- W2125836344
- Cited by
- 816
- References
- 46
- Citations by year
- 2026: 39 · 2025: 76 · 2024: 61 · 2023: 66 · 2022: 59 · 2021: 73 · 2020: 69 · 2019: 47 · 2018: 60 · 2017: 49 · 2016: 53 · 2015: 55 · 2014: 55 · 2013: 45 · 2012: 9
- FWCI
- 17.46
- Type
- journal article
- Language
- en
- Update notices
- erratum (2012-11-26)
- Open access
- green
- europepmc.org
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- University of Chicago
- Genome Canada
- Wellcome Trust
- Knut och Alice Wallenbergs Stiftelse
- National Institutes of Health
- Canadian Institutes of Health Research
- National Institute of Mental Health (R03MH085679)
- National Cancer Institute (5P30CA1405141, R01CA160458, P01CA120964, P30CA006516)
- National Institute of General Medical Sciences (R01 GM56203, R01GM056203)
- Biological and Environmental Research
- Argonne National Laboratory
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- PKM2, tetramerization, fructose-1,6-bisphosphate, small molecule activators, PKM1, tumor growth inhibition, tumor xenografts, cancer metabolism, glucose metabolism, tyrosine phosphorylation, anabolic metabolism, enzyme activation
- MeSH terms
- Animals, Biopolymers, Cell Transformation, Neoplastic, Humans, Neoplasms, Pyruvate Kinase, Blotting, Western, Enzyme Activators, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
